首頁 > 市場調查報告書 > 醫療設備

核子醫學

市場調查報告書

商品編碼

1548174

全球強子治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Hadron Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年08月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2032年，全球強子治療市場的市場規模將從2023年的15.5307億美元達到近44.2945億美元，2024-2032年研究期間的複合年成長率為12.35%。

強子療法，也稱為強子束療法，是一種先進的癌症治療方法，使用帶電粒子（例如重離子或質子）來瞄準並破壞腫瘤細胞。與傳統的 X光輻射不同，這種療法由於其精確的劑量分佈能力，可以直接向腫瘤提供大劑量的輻射，同時最大限度地減少對周圍健康組織的損害。這種療法利用了強子的物理和生物特性，將其能量更有效地沉積在特定深度（稱為布拉格峰）。這種療法對於治療深部或放射線抗性腫瘤特別有效。

市場動態

由於對先進癌症治療方案的需求不斷成長，特別是患有複雜或放射抗性腫瘤的患者，強子治療市場正在經歷成長。強子療法提供了一種精確且有針對性的癌症治療方法，這對於位於關鍵器官附近或具有挑戰性的解剖位置的腫瘤特別有益。隨著對有效且破壞性較小的癌症療法的需求不斷成長，強子療法的採用預計將會增加。技術進步為市場成長提供了重大機會。粒子加速器技術和治療計劃系統的創新提高了強子治療的精確度和效率。加速器設計的發展，例如緊湊且具有成本效益的系統，使強子治療變得更容易獲得和負擔得起，有可能導致癌症治療中心更廣泛地採用。

對個人化醫療和客製化治療方法的日益重視推動了市場的發展。強子療法為特定腫瘤部位提供標靶放射的能力符合個人化癌症護理的更廣泛趨勢，其中治療根據個別患者特徵和腫瘤概況進行客製化。此外，增加對癌症研究的投資和擴大全球醫療保健基礎設施也創造了更多機會。隨著越來越多的醫療機構採用包括強子療法在內的先進癌症治療技術，預計該市場將顯著成長。建立新的強子治療中心以及與研究機構的合作關係進一步支持市場擴張。然而，強子治療設備的高成本和治療設施的複雜性可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球強子治療市場的每個細分市場進行了包容性評估。強子治療產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

強子治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按粒子輻射類型

電子束
中子束
阿爾法粒子束
質子束
碳離子束
BETA粒子束

按申請

小兒癌症
攝護腺癌
肝癌
頭頸癌
骨與軟組織癌
肺癌
眼癌

按最終用戶

政府大學
醫院
研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲強子治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。強子治療市場的主要參與者包括Koninklijke Philips NV、Optivus Proton Therapy Inc、日立有限公司、住友商事株式會社、三菱電機公司、Elekta、IBA Worldwide、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions Llc、ProTom國際的。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：強子治療公司的競爭格局

強子治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Koninklijke Philips NV

公司概況
公司收入
產品
最新動態

Optivus Proton Therapy Inc

公司概況
公司收入
產品
最新動態

Hitachi Ltd

公司概況
公司收入
產品
最新動態

Sumitomo Corporation

公司概況
公司收入
產品
最新動態

Mitsubishi Electric Corporation

公司概況
公司收入
產品
最新動態

Elekta

公司概況
公司收入
產品
最新動態

IBA Worldwide

公司概況
公司收入
產品
最新動態

Advanced Oncotherapy

公司概況
公司收入
產品
最新動態

Varian Medical Systems Inc

公司概況
公司收入
產品
最新動態

Mevion Medical Systems

公司概況
公司收入
產品
最新動態

ProNova Solutions Llc

公司概況
公司收入
產品
最新動態

ProTom International

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115521

The global demand for Hadron Therapy Market is presumed to reach the market size of nearly USD 4429.45 Million by 2032 from USD 1553.07 Million in 2023 with a CAGR of 12.35% under the study period 2024-2032.

Hadron therapy, also known as hadron beam therapy, is an advanced cancer treatment that uses charged particles, such as heavy ions or protons, to target and destroy tumor cells. Unlike traditional X-ray radiation, this therapy delivers large doses of radiation directly to the tumor while minimizing damage to surrounding healthy tissues, thanks to its precise dose distribution capabilities. This therapy exploits hadrons' physical and biological characteristics, which deposit their energy more effectively at a specific depth, known as the Bragg peak. This therapy is particularly effective for treating deep-seated or radio-resistant tumors.

MARKET DYNAMICS

The hadron therapy market is experiencing growth driven by the increasing demand for advanced cancer treatment options, particularly for patients with complex or radiation-resistant tumors. Hadron therapy offers a precise and targeted approach to cancer treatment, which is particularly beneficial for tumors located near critical organs or in challenging anatomical positions. As the need for effective and less damaging cancer therapies grows, the adoption of hadron therapy is expected to rise. Technological advancements present significant opportunities for market growth. Innovations in particle accelerator technology and treatment planning systems enhance the precision and efficiency of hadron therapy. Developments in accelerator designs, such as compact and cost-effective systems, are making hadron therapy more accessible and affordable, potentially leading to broader adoption in cancer treatment centers.

The rising emphasis on personalized medicine & tailored treatment approaches drives the market. Hadron therapy's ability to deliver targeted radiation to specific tumor sites aligns with the broader trend of personalized cancer care, where treatments are customized based on individual patient characteristics & tumor profiles. Furthermore, increasing investments in cancer research and expanding healthcare infrastructure globally create additional opportunities. As more healthcare facilities adopt advanced cancer treatment technologies, including hadron therapy, the market is expected to experience significant growth. Establishing new hadron therapy centers and partnerships with research institutions further supports market expansion. However, the high cost of hadron therapy equipment and the complexity of treatment facilities may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hadron Therapy. The growth and trends of Hadron Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hadron Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type of Particle Radiation

Electron Beam
Neutron Beam
Alpha Particle Beam
Proton Beam
Carbon Ion Beam
Beta Particle Beam

By Application

Pediatric Cancer
Prostate Cancer
Liver Cancer
Head & Neck Cancer
Bone & Soft Tissue Cancer
Lung Cancer
Eye Cancer

By End User

Government Universities
Hospitals
Research Institutions

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hadron Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hadron Therapy market include Koninklijke Philips N.V., Optivus Proton Therapy Inc, Hitachi Ltd, Sumitomo Corporation, Mitsubishi Electric Corporation, Elekta, IBA Worldwide, Advanced Oncotherapy, Varian Medical Systems Inc, Mevion Medical Systems, ProNova Solutions Llc, ProTom International. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HADRON THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type of Particle Radiation
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HADRON THERAPY MARKET ANALYSIS BY TYPE OF PARTICLE RADIATION

5.1. Overview By Type of Particle Radiation
5.2. Historical and Forecast Data Analysis By Type of Particle Radiation
5.3. Electron Beam Historic and Forecast Sales By Regions
5.4. Neutron Beam Historic and Forecast Sales By Regions
5.5. Alpha Particle Beam Historic and Forecast Sales By Regions
5.6. Proton Beam Historic and Forecast Sales By Regions
5.7. Carbon Ion Beam Historic and Forecast Sales By Regions
5.8. Beta Particle Beam Historic and Forecast Sales By Regions

6. GLOBAL HADRON THERAPY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Pediatric Cancer Historic and Forecast Sales By Regions
6.4. Prostate Cancer Historic and Forecast Sales By Regions
6.5. Liver Cancer Historic and Forecast Sales By Regions
6.6. Head & Neck Cancer Historic and Forecast Sales By Regions
6.7. Bone & Soft Tissue Cancer Historic and Forecast Sales By Regions
6.8. Lung Cancer Historic and Forecast Sales By Regions
6.9. Eye Cancer Historic and Forecast Sales By Regions

7. GLOBAL HADRON THERAPY MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Government Universities Historic and Forecast Sales By Regions
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Institutions Historic and Forecast Sales By Regions

8. GLOBAL HADRON THERAPY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HADRON THERAPY COMPANIES

9.1. Hadron Therapy Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HADRON THERAPY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Koninklijke Philips N.V.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Optivus Proton Therapy Inc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Hitachi Ltd
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Sumitomo Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Mitsubishi Electric Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Elekta
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. IBA Worldwide
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Advanced Oncotherapy
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Varian Medical Systems Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Mevion Medical Systems
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. ProNova Solutions Llc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. ProTom International
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments